AIG announces strategic sale of Corebridge shares to Nippon Life for $3.8bn

AIG announces strategic sale of Corebridge shares to Nippon Life for $3.8bn

American International Group (AIG) has reached a significant agreement to sell approximately 120 million shares of Corebridge Financial, Inc. common stock to Nippon Life Insurance Company (Nippon Life). The transaction is valued at $31.47 per share, totaling an impressive $3.8 billion. This deal sees Nippon Life acquiring a 20% stake in Corebridge at the time […]

RenaissanceRe finalizes $3bn acquisition of AIG’s Validus Re

RenaissanceRe finalizes $3bn acquisition of AIG’s Validus Re

RenaissanceRe Holdings Ltd. (NYSE: RNR) today achieved a major milestone in its growth strategy by concluding the acquisition of Validus Re, the treaty reinsurance arm of American International Group, Inc. (“AIG”). This comprehensive deal, valued at approximately $2.985 billion, includes Validus Reinsurance Ltd., AlphaCat Managers Ltd., and the renewal rights to the Assumed Reinsurance Treaty […]

Aviva to boost presence with £460m acquisition of AIG Life UK

Aviva to boost presence with £460m acquisition of AIG Life UK

Aviva plc, a leading insurance provider, has announced its strategic acquisition of AIG Life Limited, commonly known as AIG Life UK, from Corebridge Financial, Inc., a subsidiary of American International Group, Inc. (AIG). The deal, valued at £460 million, signifies Aviva’s commitment to fortifying its presence in the protection market, where it has already demonstrated […]

BridgeBio Pharma secures $299m in funding to accelerate genetic disease drug development

BridgeBio Pharma secures $299m in funding to accelerate genetic disease drug development

BridgeBio Pharma, a leading clinical-stage biopharma company specialising in treatments for genetic diseases, has raised $299.2 million in a new funding round. The California-based firm plans to use the funds to support its drug development programmes and enhance its research and development (R&D) efforts, specifically focusing on expanding treatments for patients with unmet needs. KKR […]